Africa: 'We Could Eradicate Malaria By 2040' Says Expert After Revolutionary Vaccine Is Approved By WHO
[The Conversation Africa] The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year. Trials have shown that the R21/Matrix vaccine, developed by Oxford University together with the Serum Institute of India, reduces malaria by up to 75%. It can be manufactured cheaply and on a mass scale. The Conversation Weekly spoke to chief investigator Adrian Hill, who is also director of the Jenner Institute at the (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 4, 2023 Category: Infectious Diseases Tags: Africa Health and Medicine Malaria Source Type: news
Africa: The Long Road to a New Malaria Vaccine, Told By the Scientists Behind the Breakthrough - Podcast
[The Conversation Africa] The world has waited decades for a malaria vaccine, and now two have come along in quick succession. On October 2, the World Health Organization (WHO) recommended that a new malaria vaccine, R21, developed by the University of Oxford be rolled out for the prevention of malaria in children, just two years after another vaccine, the RTS,S, got its endorsement. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 4, 2023 Category: Infectious Diseases Tags: Africa Health and Medicine Malaria Source Type: news
The new malaria vaccine will prevent many deaths – but it’s by no means the end of the disease
The new R21/Matrix-M vaccine will be far more easily available than the first vaccine – but the reality of life in Africa will blunt its impactA new vaccine against malaria – which kills 600,000 people every year, mostly children – is to be injected into babies’ arms in 18 countries where the disease is most deadly. That’s joyous news. But the unbridled enthusiasmthe announcement has generated says as much about the sorry state of malaria control as the brilliance of scientific invention.Because this is an imperfect vaccine that at best will protect 75% of those given it. That ’s the top figure from the clinica...
Source: Guardian Unlimited Science - October 4, 2023 Category: Science Authors: Sarah Boseley Tags: Global development Malaria Vaccines and immunisation Drugs Health Science World Health Organization Africa Source Type: news
New malaria vaccine is only the 2nd to win an endorsement from the World Health Organization - and this shot is more effective and less expensive
The World Health Organization has greenlit a new, more effective vaccine for malaria, just the second to be endorsed and the first to meet the organization's efficacy standards. (Source: the Mail online | Health)
Source: the Mail online | Health - October 3, 2023 Category: Consumer Health News Source Type: news
WHO approves second, affordable vaccine in fight against deadly malaria
The World Health Organization reported an estimated 619,000 deaths in 2021 from malaria, which disproportionately affects children under 5 in Africa. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 3, 2023 Category: Consumer Health News Authors: Niha Masih Source Type: news
WHO recommends 2nd Malaria vaccine R21/Matrix-M made by Oxford-Serum Institute; says cheap, more effective
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2023 Category: Pharmaceuticals Source Type: news
Africa: WHO Approves Second Malaria Vaccine for Children
[UN News] The World Health Organization (WHO) on Monday recommended a new anti-malaria vaccine for children, a move that could offer countries a cheaper and more readily available option than the world's first shot against the parasitic disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 3, 2023 Category: Infectious Diseases Tags: Africa External Relations Health and Medicine International Organizations and Africa Malaria Source Type: news
Nigeria: WHO Recommends R21/Matrix-M Vaccine for Use Against Malaria
[Premium Times] The R21/Matrix-M vaccine is the second vaccine against malaria to be approved by WHO. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 3, 2023 Category: Infectious Diseases Tags: Health and Medicine Malaria Nigeria West Africa Source Type: news
Oxford-Serum malaria vaccine wins WHO's recommendation
The R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale at a modest cost, enabling as many as hundreds of millions of doses to be supplied to countries which are suffering a significant malaria burden, according to a news release posted on the Oxford University website. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 2, 2023 Category: Pharmaceuticals Source Type: news
Africa: New Malaria Vaccine Will Save Lives of Millions of Children
[allAfrica] Harare -- The World Health Organization (WHO) has recommended a new, inexpensive malaria vaccine to prevent malaria in children that can be produced on a massive scale. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 2, 2023 Category: Infectious Diseases Tags: Africa Children and Youth External Relations Governance Health and Medicine International Organizations and Africa Malaria Source Type: news
Africa: WHO Recommends R21/Matrix-M Vaccine for Malaria Prevention in Updated Advice On Immunization
[WHO] The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children. The recommendation follows advice from the WHO: Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) and was endorsed by the WHO Director-General following its regular biannual meeting held on 25-29 September. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 2, 2023 Category: Infectious Diseases Tags: Africa Children and Youth External Relations Health and Medicine International Organizations and Africa Malaria Source Type: news
Africa: RBM Partnership to End Malaria welcomes WHO's recommendation of world's second malaria vaccine
[RBM] Global malaria community calls for increased investment in development and scale-up of malaria innovations following R21 vaccine announcement- but RBM Partnership warns "it's not the only solution". (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 2, 2023 Category: Infectious Diseases Tags: Africa External Relations Health and Medicine International Organizations and Africa Malaria NGOs and Civil Society Source Type: news
Africa: Oxford R21/Matrix-M™ malaria vaccine receives World Health Organization recommendation for use paving the way for global roll-out
[Oxford University] The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax's adjuvant is critical to reducing over half a million malaria-related deaths annually. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 2, 2023 Category: Infectious Diseases Tags: Africa Asia, Australia, and Africa Children and Youth Europe and Africa External Relations Health and Medicine Malaria Science and Biotechnology Source Type: news
Africa: Oxford R21/Matrix-MTM malaria vaccine receives World Health Organization recommendation for use paving the way for global roll-out
[Oxford University] The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax's adjuvant is critical to reducing over half a million malaria-related deaths annually. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 2, 2023 Category: Infectious Diseases Tags: Africa Asia, Australia, and Africa Children and Youth Europe and Africa External Relations Health and Medicine Malaria Science and Biotechnology Source Type: news
Malaria vaccine by Oxford & Serum Institute of India gets WHO recommendation
The University of Oxford and Serum Institute of India (SII) have developed a malaria vaccine, which has been recommended for use by the World Health Organization (WHO). The R21/Matrix-M vaccine can be produced at a large scale and low cost, making it accessible to countries with a high malaria burden. (Source: The Economic Times)
Source: The Economic Times - October 2, 2023 Category: Consumer Health News Source Type: news
